Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Other Operating Expenses (2012 - 2025)

Palatin Technologies' (PTN) quarterly Other Operating Expenses came in at -$2.3 million in Q2 2025, down 114.97% YoY from $15.6 million in Q2 2024, and down 193.28% on a QoQ basis from $2.5 million in Q4 2024.

Palatin Technologies (PTN) Other Operating Expenses (2012 - 2025) Analysis & Trends

Palatin Technologies (PTN) has 13 years of Other Operating Expenses data on file, last reported at -$2.3 million in Q2 2025.

  • Quarterly Other Operating Expenses fell 114.97% year-over-year to -$2.3 million in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$2.3 million (down 112.9% YoY) and the FY2025 annual result came in at -$5.2 million, down 167.44% from the prior year.
  • Other Operating Expenses retreated to -$2.3 million in Q2 2025, from $2.5 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $15.6 million in Q2 2024 to a low of -$7.8 million in Q4 2023.
  • A 5-year average of $518350.4 and a median of $25202.0 in 2024 frame the typical range for Other Operating Expenses.
  • Annual changes were most pronounced in 2024 — Other Operating Expenses soared 131.96% — and 2025, when it slumped 114.97%.
  • Tracing PTN's Other Operating Expenses over 5 years: stood at -$4.4 million in 2021, then soared by 101.96% to $86496.0 in 2022, then plunged by 9144.91% to -$7.8 million in 2023, then soared by 131.96% to $2.5 million in 2024, then plunged by 193.28% to -$2.3 million in 2025.
  • The last three Other Operating Expenses figures came in at -$2.3 million (Q2 2025), $2.5 million (Q4 2024), and $15.6 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Palatin Technologies 40.37 Mn 40.37 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 -2.33 Mn
Dec 31, 2024 2.50 Mn
Jun 30, 2024 15.58 Mn
Mar 31, 2024 25,202.00
Dec 31, 2023 -7.82 Mn
Sep 30, 2022 86,496.00
Jun 30, 2021 -4.41 Mn
Sep 30, 2020 1.62 Mn
Jun 30, 2019 116.00
Mar 31, 2019 222.00
Dec 31, 2018 -221.00
Sep 30, 2018 -273.00
Jun 30, 2018 -8.34 Mn
Mar 31, 2018 -9.47 Mn
Dec 31, 2017 -7.66 Mn
Sep 30, 2017 -15.69 Mn
Jun 30, 2017 -5.48 Mn
Mar 31, 2017 -13.82 Mn
Dec 31, 2016 -9.43 Mn
Sep 30, 2016 -12.42 Mn